- Home
- AU vs IQV Comparison
AU vs IQV Comparison
Compare AU & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AU
- IQV
- Stock Information
- Founded
- AU 1944
- IQV 1982
- Country
- AU United States
- IQV United States
- Employees
- AU N/A
- IQV N/A
- Industry
- AU Precious Metals
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- AU Basic Materials
- IQV Health Care
- Exchange
- AU Nasdaq
- IQV Nasdaq
- Market Cap
- AU 30.2B
- IQV 31.0B
- IPO Year
- AU 1972
- IQV 2013
- Fundamental
- Price
- AU $74.65
- IQV $200.89
- Analyst Decision
- AU Buy
- IQV Strong Buy
- Analyst Count
- AU 5
- IQV 20
- Target Price
- AU $47.30
- IQV $229.15
- AVG Volume (30 Days)
- AU 3.2M
- IQV 1.3M
- Earning Date
- AU 11-06-2025
- IQV 10-28-2025
- Dividend Yield
- AU 1.24%
- IQV N/A
- EPS Growth
- AU 1303.37
- IQV N/A
- EPS
- AU 3.81
- IQV 6.92
- Revenue
- AU $7,649,000,000.00
- IQV $15,700,000,000.00
- Revenue This Year
- AU $62.30
- IQV $6.00
- Revenue Next Year
- AU N/A
- IQV $4.98
- P/E Ratio
- AU $19.61
- IQV $29.01
- Revenue Growth
- AU 54.59
- IQV 3.60
- 52 Week Low
- AU $22.45
- IQV $134.65
- 52 Week High
- AU $75.96
- IQV $237.34
- Technical
- Relative Strength Index (RSI)
- AU 75.89
- IQV 61.87
- Support Level
- AU $69.74
- IQV $176.16
- Resistance Level
- AU $75.96
- IQV $209.48
- Average True Range (ATR)
- AU 2.17
- IQV 5.84
- MACD
- AU 0.38
- IQV 2.14
- Stochastic Oscillator
- AU 89.24
- IQV 76.20
About AU AngloGold Ashanti PLC
Anglogold Ashanti PLC is one of the gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from the Africa region which includes its operations of the Kibali, Iduapriem, Obuasi, Siguiri, and Geita mines.
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.